Lugano, Switzerland, 27 November 2024 – The ESMO Asia Congress 2024 is the annual event dedicated to multidisciplinary oncology in the Asian region. It will feature a broad spectrum of topics in cancer research, including novel treatment modalities, in-depth discussions on the management of specific cancer types, pan-Asian trials and subgroup analyses of cutting-edge studies relevant for the patients in the area. Data will be presented and discussed by leading experts from across Asia and beyond. The congress will be held onsite in Singapore from 6-8 December, with no virtual option available.
Programme highlights
- Subgroup analyses for evaluating recently approved standard of care therapies in urothelial carcinoma among the Asian population.
-
Related content: Abstracts 269O, 270O, 271O
-
-
News Insights on unresectable hepatocellular carcinoma: from an Asian subgroup analysis of a Phase-3 trial on the first line-treatment to novel data on overall survival.
-
Asian perspectives on recent practice-changing Phase-3 trials for the treatment of anal, bladder, liver, lung, cervical and breast cancers.
- Related content: Special Session 1 on Saturday 7 December, 11:00-12:30 SGT; Special Session 2 on Saturday 7 December, 11:00-12:10 SGT
-
Insights on the genetics, biology and practice differences between the West and Asia in light of the new Pan-Asian Guidelines Adaptations (PAGA) for biliary, lung and ovarian cancers.
- Related content: Special Session on Sunday 8 December, 10:45-12:15 SGT
-
Outlook on the Asian region: from cancer prevention and national screening programs to the management of patients with rare cancers, through environmental and infection-related cancers.
- Related content: Special Sessions in collaboration with endorsing societies on Friday 6 December 16:45-18:15 SGT
-
Current perspectives on preventive oncology, including prevention of virus-induced cancers, the potential of molecular techniques for early detection and the role of AI in histo-pathology.
- Related content: Educational Session on Saturday 7 December, 14:30-16:00 SGT
-
Discussions on the potential of cell and gene therapies for solid tumors, including the use of virotherapy, the future of CAR T cell and TIL therapies and the opportunities for clinical practice.
- Related content: Educational Session on Friday 6 December, 10:15-11:45 SGT
-
Insights on self-management of anxiety and depression in patients with fear of recurrence and on cognitive problems affecting functional outcomes after cancer treatment in young adults.
- Related content: Abstracts 526MO, 528MO
The results of the studies presented at the congress will be published online as a supplement to Annals of Oncology. The abstract titles can be viewed through the online programme.
Keynote Lecture
“Obesity: Impact on cancer prevalence, management and outcomes - Actions to improve on prevention” by Elick A. Narayan, 6 December 2024, 09:35 - 10:00 SGT.
ESMO Patient Engagement Summit
The first edition of the ESMO Patient Engagement Summit will take place during the ESMO Asia Congress 2024. This dialogue platform will bring together the voices of patients, healthcare professionals, and industry representatives to identify the challenges and opportunities facing patients in the Asia-Pacific region. The aim is to shape impactful health policies while exploring patient engagement strategies to strengthen a collaborative decision-making approach in the multiple dimensions of cancer care, including prevention, access to diagnosis and treatments, survivorship, and patient rights.
Press accreditation
ESMO welcomes press representatives working for recognised press outlets interested in obtaining information and reporting on cancer issues, upon presentation of a letter of assignment and a valid press card. Press representatives are required to observe and abide by the ESMO Policy on Press Activities and the embargo schedule for ESMO Asia Congress 2024. To apply for press accreditation, please fill out the form available here. Please be kindly informed that onsite press accreditation will not be available.
Third Parties Media registration
Third Parties Media representatives and Filming Crews not eligible as press, must abide by the ESMO Policy on Media Activities Organised by Third Parties and can request a Third Parties Media badge through registration@esmo.org (Cc media@esmo.org).
Further information
ESMO Press Office
press@esmo.org
Notes to Editors
Please make sure to use the official name of the meeting in your reports: ESMO Asia Congress 2024 and the official congress hashtag #ESMOAsia24. Follow it to stay up to date and use it to take part in the conversation on X(Twitter), LinkedIn, Facebook, Instagram, YouTube.
About the European Society for Medical Oncology (ESMO)
Representing more than 40,000 oncology professionals from more than 170 countries and territories worldwide, ESMO is a reference for oncology education and information. Driven by a shared determination to secure the best possible outcomes for patients, ESMO is committed to standing by those who care about cancer through addressing the diverse needs of #ONEoncologycommunity, offering #educationforLIFE, and advocating for #accessiblecancerCARE. www.esmo.org